Medicare Tests AI-Based Prior Authorization for Devices
CMS will launch a model in January to test AI-enabled prior authorization review for 15 devices and procedures to reduce "wasteful care" under fee-for-service Medicare.
Market Pathways covers the people, challenges, and opportunities impacting the global medtech regulatory, reimbursement, and policy communities. We invite you to explore our coverage. Think Strategically.
Subscribe Today
CMS will launch a model in January to test AI-enabled prior authorization review for 15 devices and procedures to reduce "wasteful care" under fee-for-service Medicare.
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Predetermined Change Control Plans in June 2025. Updated June 30.
A sortable and searchable running inventory of global medtech regulatory and policy official documents, including rules, guidance documents, memos, white papers, and more from national authorities, non-governmental groups, and global organizations.